Brazilian consensus on non-cystic fibrosis bronchiectasis
Authors:
- Mônica Corso PereiraMPMônica Corso Pereira
- Rodrigo Abensur AthanazioRARodrigo Abensur Athanazio
- Paulo de Tarso Roth DalcinPDPaulo de Tarso Roth Dalcin
- Mara Rúbia Fernandes de FigueiredoMFMara Rúbia Fernandes de Figueiredo
- Mauro GomesMGMauro Gomes
- Clarice Guimarães de FreitasCFClarice Guimarães de Freitas
- Ilma Aparecida PaschoalIPIlma Aparecida Paschoal
- Samia Zahi RachedSRSamia Zahi Rached
- Rosemeri MauriciRMRosemeri Maurici
Open Access
- 1 January 2019
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 45 (4) , e20190122
Abstract
Bronchiectasis is a condition that has been increasingly diagnosed by chest HRCT. In the literature, bronchiectasis is divided into bronchiectasis secondary to cystic fibrosis and bronchiectasis not associated with cystic fibrosis, which is termed non-cystic fibrosis bronchiectasis. Many causes can lead to the development of bronchiectasis, and patients usually have chronic airway symptoms, recurrent infections, and CT abnormalities consistent with the condition. The first international guideline on the diagnosis and treatment of non-cystic fibrosis bronchiectasis was published in 2010. In Brazil, this is the first review document aimed at systematizing the knowledge that has been accumulated on the subject to date. Because there is insufficient evidence on which to base recommendations for various treatment topics, here the decision was made to prepare an expert consensus document. The Brazilian Thoracic Association Committee on Respiratory Infections summoned 10 pulmonologists with expertise in bronchiectasis in Brazil to conduct a critical assessment of the available scientific evidence and international guidelines, as well as to identify aspects that are relevant to the understanding of the heterogeneity of bronchiectasis and to its diagnostic and therapeutic management. Five broad topics were established (pathophysiology, diagnosis, monitoring of stable patients, treatment of stable patients, and management of exacerbations). After this subdivision, the topics were distributed among the authors, who conducted a nonsystematic review of the literature, giving priority to major publications in the specific areas, including original articles, review articles, and systematic reviews. The authors reviewed and commented on all topics, producing a single final document that was approved by consensus.Keywords
This publication has 150 references indexed in Scilit:
- Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infectionJournal of Clinical Investigation, 2011
- British Thoracic Society guideline for non-CFbronchiectasisThorax, 2010
- Tuberculosis, bronchiectasis and chronic airflow obstructionRespirology, 2010
- Lung Transplantation for Advanced BronchiectasisSeminars in Respiratory and Critical Care Medicine, 2010
- Treatment of bronchiectasis in adultsBMJ, 2007
- Lung Transplantation for Non-Cystic Fibrosis Bronchiectasis: Analysis of a 13-Year ExperienceThe Journal of Heart and Lung Transplantation, 2005
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- Short acting beta2-agonists for bronchiectasisCochrane Database of Systematic Reviews, 2003
- Long-acting beta2-agonists for bronchiectasisCochrane Database of Systematic Reviews, 2001
- RESPIRATORY MORBIDITY AND LUNG FUNCTION AFTER WHOOPING-COUGHThe Lancet, 1983